Her2, c-kit EGFR and akt1 Expression in Carcinosarcomas of Female Genital Tract: Prognostic Factors or Potential Markers for Targeted Therapies
Conditions
Gynecological Cancers
Trial Phase
Trial Purpose and Description
Trial Purpose
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Female
Eligibility Criteria
- Sponsor:
- Yale
- Dates:
- April 2011
- Last Updated:
- Study HIC#:
- 1104008301
Clinicaltrials.gov ID: Yale8218761
For more information about this trial, contact:
Investigator
Ozlen Saglam, MD
Principal Investigator
